GoviEx Uranium Inc.
TSX VENTURE : GXU

GoviEx Uranium Inc.

December 23, 2016 14:33 ET

GoviEx Completes Private Placement Financing

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 23, 2016) -

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

GoviEx Uranium Inc. (TSX VENTURE:GXU) ("GoviEx" or the "Company") today announced that, further to its news release of December 19, 2016, it has closed the second and final tranche of its private placement financing (the "Private Placement"). In aggregate, the Company issued a total of 50 million Units between the first and second tranches at a price of C$0.10 per Unit, for gross proceeds to the Company of approximately C$5.0 Million.

The net proceeds from the Private Placement will be used to fund continued exploration and development activities on the Company's projects and for general corporate purposes. The funds also will enable the Company to pursue discussions related to strategic opportunities and potential transactions.

All securities issued under the second tranche of this Private Placement will be subject to a customary hold period and may not be traded before April 24, 2017. In addition, securities issued to subscribers in the United States will be subject to a hold period under the Securities Act of 1933 (the "1933 Act") and can only be resold in strict compliance with the applicable exemptions from the registration requirements of the 1933 Act.

Each Unit consists of one (1) Class A common share and one (1) Class A common share purchase warrant (a "Warrant") of the Company. Each Warrant entitles the holder to purchase one (1) Class A common share of the Company for US$0.15 for five years from the date of issuance, until either December 19, 2021 or December 23, 2021, as applicable.

GoviEx insiders subscribed for a total of C$60,820 or 608,200 Units. The Company paid total finders' fees of approximately C$201,840 and issued a total of 2,018,400 finders' warrants, each allowing the holder to subscribe for one (1) Class A common share at an exercise price of US$0.075 until December 19, 2019.

The Private Placement remains subject to the final acceptance of the TSX Venture Exchange.

About GoviEx Uranium

GoviEx is a mineral resource company focused on the exploration and development of a diversified portfolio of uranium projects in Africa. GoviEx's principal objective is to become a significant uranium producer through the continued exploration and development of its flagship Madaouela Project in Niger, as well as its Mutanga Project in Zambia, and its uranium-copper-silver exploration Falea Project in Mali.

Visit GoviEx's website: www.goviex.com

Cautionary statement regarding forward-looking statements

This news release may contain forward-looking information within the meaning of applicable securities laws. All information and statements other than statements of current or historical facts contained in this news release are forward-looking information.

Forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in GoviEx's periodic filings with Canadian securities regulators. When used in this news release, words such as "will", "could", "plan", "estimate", "expect", "intend", "may", "potential", "should," and similar expressions, are forward-looking statements. Information provided in this document is necessarily summarized and may not contain all available material information.

Forward-looking statements include those with respect to Company's use of the proceeds raised under the Private Placement. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurances that its expectations will be achieved. Such assumptions, which may prove incorrect, include the following: (i) GoviEx will be successful in its efforts to pursue the exploration activities referred to in this news release, (ii) GoviEx's management will not identify and pursue other business objectives using the proceeds of the Private Placement and (iii) the price of uranium will remain sufficiently high and the costs of advancing the Company's mining projects sufficiently low so as to permit GoviEx to implement its business plans in a profitable manner. Factors that could cause actual results to differ materially from expectations include (i) the Company's failure to make effective use of the proceeds of the Private Placement, (ii) the failure of the Company's projects, for technical, logistical, labour-relations or other reasons, (iii) the Company's inability to obtain the necessary final regulatory approvals for the Private Placement, (iv) a decrease in the price of uranium below what is necessary to sustain the Company's operations, (v) an increase in the Company's operating costs above what is necessary to sustain its operations, (vi) accidents, labour disputes or the materialization of similar risks, (vii) a deterioration in capital market conditions that prevents the Company from raising the funds it requires on a timely basis and (viii) generally, the Company's inability to develop and implement a successful business plan for any reason.

In addition, the factors described or referred to in the section entitled "Financial Risks and Management Objectives" in the MD&A for the year ended December 31, 2015, of GoviEx, which is available on the SEDAR website at www.sedar.com, should be reviewed in conjunction with the information found in this news release.

Although GoviEx has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, no assurance can be given that any events anticipated by the forward-looking information in this news release will transpire or occur, or if any of them do so, what benefits that GoviEx will derive there from. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this news release, and GoviEx disclaims any intention or obligation to update or revise such information, except as required by applicable law.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933 (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.

Neither the TSX Venture Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.

Contact Information